Health Affairs

Health Affairs, 27, no. 2 (2008): w96-w104 (Published online 23 January 2008) doi: 10.1377/hlthaff.27.2.w96 © 2008 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Full Text (HTML) Reprint (PDF) Online Appendix Submit a response to this article Comments: View responses Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmier, J. Articles by Mahadevia, P. J. Search for Related Content PubMed PubMed Citation Articles by Schmier, J. Articles by Mahadevia, P. J. Related Collections Health Promotion/Disease Prevention Maternal And Child Health Consumer Issues Vaccines

Web Exclusives

MARKETWATCH

Benefits And Costs Of Immunizing Children Against Influenza At School: An Economic Analysis Based On A Large-Cluster Controlled Clinical Trial

Jordana Schmier, Su Li, James C. King, Jr., Kristin Nichol and Parthiv J. Mahadevia

Current influenza vaccination recommendations focus on immunizing high-risk people; however, influenza mortality and morbidity remain elevated. U.S. policymakers are considering expansion of flu vaccination recommendations to include school-age children (ages 5–18). Children are at risk for flu and propagate epidemic spread. Immunizing children at school offers an efficient approach to covering this population. This study examines the cost consequences of a large multistate, school-based influenza immunization program. The results show that immunization reduces disease among children and adults and is cost-saving to society. An epidemiologically based influenza immunization policy might be an important supplement to the existing risk-based policy.

                      What's this?

This article has been cited by other articles:

				B.-K. Yoo, P. G. Szilagyi, S. J. Schaffer, S. G. Humiston, C. M. Rand, C. S. Albertin, P. Vincelli, A. K. Blumkin, L. P. Shone, and M. S. Coleman Cost of Universal Influenza Vaccination of Children in Pediatric Practices Pediatrics, December 1, 2009; 124(Supplement_5): S499 - S506. [Abstract] [Full Text] [PDF]

Comments: